TMO vs GILD
By Alex · Tickerpine
Thermo Fisher Scientific Inc. vs Gilead Sciences, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | TMO | GILD |
|---|---|---|
| Price | $700.22 | $168.08 |
| Market cap | $259.44B | $208.48B |
| P/E ratio | 36.9 | — |
| ROE | 13.38% | -22.45% |
| Profit margin | 14.94% | -12.46% |
| Revenue growth | 9.10% | 6.80% |
| Dividend yield | 0.27% | 1.95% |
| Beta | 0.84 | 0.37 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
TMO vs GILD in plain English
- TMO is the bigger company — about 1.2× the market cap of GILD.
- TMO earns a higher return on equity (13% vs -22%).
- TMO is growing revenue faster (9% vs 7%).
- GILD has the higher dividend yield (1.95% vs 0.27%).
How would $1,000 have done in each?
TMO return calculator
See what $1,000 in Thermo Fisher Scientific Inc. would be worth today.
GILD return calculator
See what $1,000 in Gilead Sciences, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.